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Abstract
Objective—To evaluate a new approach for creating a composite measure of cognitive function,
we calibrated a measure of general cognitive performance from existing neuropsychological
batteries.
Methods—We applied our approach in an epidemiologic study and scaled the composite to a
nationally representative sample of older adults. Criterion validity was evaluated against standard
clinical diagnoses. Convergent validity was evaluated against the Mini-Mental State Examination
(MMSE).
Results—The general cognitive performance factor was scaled to have a mean=50 and SD=10 in
a nationally representative sample of older adults. A cut-point of approximately 45, corresponding
with an MMSE of 23/24, optimally discriminated participants with and without dementia
(sensitivity=0.94; specificity=0.90; AUC=0.97). The general cognitive performance factor was
internally consistent (Cronbach's alpha=0.91) and provided reliable measures of functional ability
across a wide range of cognitive functioning. It demonstrated minimal floor and ceiling effects,
which is an improvement over most individual cognitive tests.
Conclusions—The cognitive composite is a highly reliable measure, with minimal floor and
ceiling effects. We calibrated it using a nationally representative sample of adults over age 70 in
the US and established diagnostically relevant cut-points. Our methods can be used to harmonize
neuropsychological test results across diverse settings and studies.
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Introduction
Despite its central role in the daily lives of older adults, there is no widely used,
standardized method of assessing overall or global cognitive function across a wide range of
functioning. Over 500 neuropsychological tests exist for clinical and research purposes (1).
This tremendous diversity complicates comparison and synthesis of findings about cognitive
functioning across a broad range of performance in multiple samples in which different
neuropsychological batteries were administered. Although test batteries are used to examine
domain-specific cognitive function, summary measures provide global indices of function
(2). Brief global cognitive tests such as the Mini-Mental State Examination (MMSE) and
others are limited by prominent ceiling effects and skewed score distributions (3-6), thus
evaluating a limited range of cognitive function. These measurement properties substantially
hamper the capacity to measure longitudinal change, since score ranges are limited and a
point change has different meanings across the range of values (3,7). Summary measures of
general cognition, if properly calibrated, may be more sensitive to impairments across a
broader range of cognitive function and be more sensitive to changes over time (8).
Approaches to creating summary cognitive measures have been limited and controversial.
One approach involves standardizing scores of component cognitive tests, which are then
averaged into a composite (9,10). Although widely used, this approach is limited because
standardizing variables does not address skewed response distributions, does not allow
differential weighting of tests, and ultimately does not facilitate comparisons of findings
across studies. An alternative approach uses latent variable methods to summarize tests. The
tests are weighted and combined in a composite measure that has more favorable
measurement properties including minimal floor and ceiling effects, measurement precision
over a wide range of function, and interval-level properties that make the composite optimal
for studying longitudinal change (e.g., 8,11).
In a previous study, Jones and colleagues (12) used confirmatory factor analysis to develop a
general cognitive performance factor from a neuropsychological battery (13). This measure
was shown to be unidimensional and internally consistent (Cronbach's alpha=0.82). The
factor was defined by high loadings on six of the ten component tests. The cognitive factor
was designed to be sensitive to a wide range of cognitive function from high functioning to
scores indicative of dementia. Scores were normally distributed and reliable (reliability
index>0.90). With these properties, the general cognitive performance factor provides a
robust approach to assess cognitive function over time.
Despite these clear advantages, an important limitation of the general cognitive performance
factor is that its scores are not yet clinically interpretable or generalizable across studies. To
address this limitation, the aims of the present study were to: (1) calibrate a general
cognitive performance factor to a nationally representative sample of adults over age 70 in
the US, (2) validate the general cognitive performance factor against reference standard
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clinical diagnoses, (3) examine convergent validity of the cognitive performance factor
score, and (4) identify clinically meaningful cut-points for the cognitive factor score. Our
overall goal was to create a clinically meaningful measurement tool, and importantly, to
demonstrate an approach that is generalizable to other different neuropsychological test
batteries on a broader scale.
Materials and Methods
Study samples
Participants were drawn from the Successful AGing after Elective Surgery (SAGES) study
and the Aging, Demographics, and Memory Study (ADAMS), a substudy of the Health and
Retirement Study. SAGES is a prospective cohort study of long-term cognitive and
functional outcomes of hospitalization in elective surgery patients. After recruitment, a
neuropsychological battery was administered to participants just before surgery and peri-
annually for up to three years. Because data collection was ongoing at the time of this study,
we used pre-operative data for the first 300 patients enrolled. Eligible participants were at
least 70 years of age, English-speaking, and scheduled for elective surgery at one of two
academic teaching hospitals in Boston, MA. Exclusion criteria included evidence of
dementia or delirium at baseline. Study procedures were approved by the Institutional
Review Board at the Beth Israel Deaconess Medical Center.
ADAMS is a nationally representative sample of 856 older adults in the United States
interviewed in 2002-2004 (14). Its parent study, the Health and Retirement Study, is a
longitudinal survey of over 20,000 community-living retired persons. ADAMS, which began
as a population-based study of dementia, initially identified a stratified random sample of
1,770 participants; 687 refused and 227 died before they were interviewed, yielding 856
participants. Participants with probable dementia and minorities were over-sampled. We
used survey weights to account for the complex survey design and to make estimates
representative of adults over age 70 in the US (15). ADAMS was approved by Institutional
Review Boards at the University of Michigan and Duke University.
Measures
Neuropsychological test batteries—In SAGES, a neuropsychological test battery was
administered during an in-person evaluation that consisted of 11 tests of memory, attention,
language, and executive function. We used ten tests from the ADAMS battery, of which
seven were in common with SAGES (Table 1). As explained in more detail in the statistical
analysis, our modeling approach allows cognitive ability to be estimated based on responses
to any subset of cognitive tests (16).
Clinical diagnoses—Clinical diagnoses, grouped as normal cognitive function, cognitive
impairment-no dementia (CIND), and all-cause dementia, were assigned in ADAMS by an
expert clinical consensus panel (14,17). Diagnoses were determined after a review of data
collected during in-home participant assessments, which included neuropsychological and
functional assessments from participants and proxies. A diagnosis of dementia was based on
the Diagnostic and Statistical Manual of Mental Disorders III-R and IV (18,19) and for the
Gross et al. Page 3
Neuroepidemiology. Author manuscript; available in PMC 2015 January 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
present study included probable and possible AD, probable and possible vascular dementia,
dementia associated with other conditions (Parkinson's disease, normal pressure
hydrocephalus, frontal lobe dementia, severe head trauma, alcoholic dementia, Lewy Body
dementia), and dementia of undetermined etiology. CIND was defined as functional
impairment that did not meet criteria for all-cause dementia or as below-average
performance on any test (17). CIND included participants with Mild Cognitive Impairment
or cognitive impairment due to other causes (e.g., vascular disease, depression, psychiatric
disorder, mental retardation, alcohol abuse, stroke, other neurological condition).
MMSE—The MMSE is a brief 30-point cognitive screening instrument used to assess
global mental status. The MMSE is widely used in clinical and epidemiologic settings. Its
validity as a screening test for all-cause dementia in clinical populations has been previously
established (20,21). George (22) recommended cut-points of 23/24 for moderate cognitive
impairment and 17/18 for severe cognitive impairment. These cut-points have been widely
applied in clinical and research settings (21-25). MMSE 9/10 has also been used to indicate
severe impairment (26). Although not a preferred test for identification of Mild Cognitive
Impairment (21), cut-points of 26/27 (23,27,28) and 28/29 (29) have been used for that
purpose. Although the MMSE has poor measurement properties and ceiling effects, we used
is as a standard for comparison in this study because it remains widely used and its scores
and cutoffs are well-recognized.
Statistical analyses
We used descriptive statistics to characterize the SAGES and ADAMS samples. Analyses
were subsequently conducted in four steps: (1) score the general cognitive performance
factor in SAGES and calibrate it to ADAMS using item response theory (IRT) methods, (2)
assess criterion validity of the general cognitive performance factor using reference standard
clinical ratings in ADAMS, (3) assess convergent validity of the general cognitive
performance factor with the MMSE, and (4) identify cut-points on the general cognitive
performance factor corresponding to published MMSE cut-points.
Score the general cognitive performance factor in SAGES and calibrate to
ADAMS—We calculated internal consistency of the cognitive tests in SAGES using
Cronbach's alpha (13). The Cronbach's alpha statistic has a theoretical range between 0 and
1, with 1 indicating high internal consistency. A generally accepted reliability for analysis of
between-person group differences is ≥0.80 and for within-person change is ≥0.90 (13). Next,
we calculated the general cognitive performance factor in SAGES from a categorical
variable factor analysis of cognitive tests. The general cognitive performance factor score
was scaled to have a mean of 50 and standard deviation (SD) of 10 in the US population
over age 70. The factor analysis is consistent with the IRT graded response model, and
facilitated precise estimation of reliability across the range of performance (30-33). In IRT,
reliability is conceptualized as the complement of the squared standard error of
measurement (SEM) (34). The SEM is estimated from the test information function, which
varies over the range of ability. We described the precision of the measure over the range of
general cognitive performance using the standard error of measurement calculated based on
the IRT measurement model (35,36).
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To scale the general cognitive performance factor in SAGES to the nationally representative
ADAMS sample, we took advantage of tests in common between studies to calibrate scores
in SAGES to ADAMS (3). We categorized cognitive tests into up to 10 discrete equal-width
categories (37) to avoid model convergence problems caused by outlying values (38) and to
place all tests on a similar scale (12) (see Supplemental Table 2). Tests in common between
studies were categorized based on the sample distribution in ADAMS. We assigned model
parameters for anchor tests in the SAGES factor analysis based on corresponding estimates
from the ADAMS-only model that used population-based survey weighting. This procedure
allowed us to scale the general cognitive performance factor to reflect the general population
of US adults aged 70 and older. Importantly, because the IRT model handles missing data
under the assumption that cognitive performance data are missing at random conditional on
variables in the model, general cognitive performance can be calculated for each participant
based on responses to any subset of cognitive tests as long as not all test scores are missing.
The factor score is the mean of the posterior probability distribution of the expected a priori
latent trait estimate. The posterior probability distribution refers to the conditional density of
the latent cognitive performance trait given observed cognitive test scores. Because the
factor is computed on the basis of all available information in a participant's response
patterns, it can be computed regardless of missing tests (39).
We conducted diagnostic procedures using Monte Carlo simulation by generating 100,001
hypothetical observations with the MMSE and all SAGES and ADAMS cognitive measures.
Simulated cognitive test distributions matched those of our empirical samples. This
simulation allowed us to rigorously compare SAGES and ADAMS scores to the overall
general cognitive performance factor using correlations and Bland-Altman plots to examine
systematic differences between the measures (40).
Criterion validity of the general cognitive performance factor—To evaluate
criterion validity for distinguishing dementia and CIND, we used logistic regression. We
report overall areas under the curve (AUC) for the general cognitive performance factor and
diagnostic characteristics for the score that maximized sensitivity and specificity (41).
Convergent validity of the general cognitive performance factor—We correlated
the general cognitive performance factor with MMSE using Pearson correlation coefficients.
Link the general cognitive performance factor and MMSE—The MMSE is a
widely used screening test for global cognitive status. Because of its widespread use, many
clinicians and researchers are familiar with its scores. Thus, the MMSE provides a set of
readily recognizable cutpoints which we utilized as guideposts for comparison with the
general cognitive performance measure. To produce a crosswalk between the general
cognitive performance factor and MMSE, we used equipercentile linking methods to
correlate scores (42). This step allowed the direct comparison of general cognitive
performance factor scores that correspond to MMSE scores. Equipercentile linking identifies
scores on two measures (MMSE and general cognitive performance factor) with the same
percentile rank, and assigns general cognitive performance a value from the reference test,
MMSE, at that percentile. This approach is appropriate when two tests are on different
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scales, and is most useful when the distribution of the reference test is not normally
distributed (43).
Results
In SAGES (n=300), most participants were female (56%), white (95%), on average 77 years
old (range 70, 92), and had at least a college education (70%)(Table 1). Few had dementia
(n=5, 1.7%) or CIND (n=19, 6.3%). By comparison, in ADAMS (n=856), which is
representative of persons over age 70, participants were mostly female (61%), white (89%),
on average 79 years of age (range 70, 110), and 37% had at least a college education.
Relative to SAGES, the ADAMS sample was older (P<0.001), more ethnically diverse
(P=0.001), less highly educated (P<0.001), and had higher levels of cognitive impairment
(n=308, 13.7% had dementia and n=241, 22.0% had CIND).
Derivation of the general cognitive performance factor in SAGES and calibration to
ADAMS
By design, the general cognitive performance factor in ADAMS had a mean of 50 and
standard deviation (SD) of 10. The general cognitive performance factor in SAGES was 0.9
SD above the national average, reflecting their higher education and younger average age.
The cognitive tests in ADAMS were internally consistent (Cronbach's alpha=0.91). The
reliability of the general cognitive performance factor, derived based on the standard error of
measurement, was above 90% for scores between 40 and 70, which included 84% of the
ADAMS sample. Correlations between the general cognitive performance factor and items
from SAGES were above 0.80, with the exception of HVLT delayed recall (r=0.65). The
tests represent multiple domains including memory, executive function, language, and
attention, suggesting the factor represents general cognitive performance and is not
dominated by a particular cognitive domain. Figure 1 demonstrates that general cognitive
performance factor scores in SAGES and ADAMS were normally distributed; on average,
SAGES participants had higher levels of cognitive function.
Using simulated data, the correlation between the study-specific general cognitive
performance factor for SAGES and ADAMS was above 0.97. Bland-Altman plots further
revealed no systematic bias across the range of general cognitive performance scores,
suggesting the general cognitive performance factor was not measured differently across the
two studies (Supplemental Figure 1).
Criterion validity of the general cognitive performance factor
Figure 2 shows receiver operating curves for distinguishing dementia and CIND in
ADAMS. The general cognitive performance factor score that best discriminated dementia
participants from cognitively normal participants was less than 44.8 (sensitivity = 0.94;
specificity = 0.90; Figure 2, right panel). This cut-point correctly classified 94% of the
sample. The area under the curve (AUC) was 0.97. The general cognitive performance
factor score that best discriminated CIND participants from cognitively normal participants
was less than 49.5 (sensitivity = 0.80, specificity = 0.76; Figure 2, left panel). This cut-point
correctly classified 79% of the sample (AUC=0.84).
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The AUC for the general cognitive performance factor was significantly greater than the
AUC for each constituent test (Supplemental Table 1). The only exception was for
immediate word recall, which was superior for predicting dementia.
Convergent validity of the general cognitive performance factor
The correlation between the general cognitive performance factor and the MMSE was 0.91
in ADAMS (P<0.001), indicating strong evidence of convergent validity.
Crosswalk between general cognitive performance factor and MMSE
The equipercentile linking procedure is illustrated in Figure 3. Scores for the general
cognitive performance factor and MMSE were matched based on percentile ranks. For
example, a score of 24 on the MMSE, for example, has the same percentile rank as a score
of 45 on the general cognitive performance factor.
After equipercentile-linking the general cognitive performance factor with the MMSE, the
score corresponding to an MMSE cut-point of 23/24 was <45.2, or 0.48SD below the
national average (Table 2). This cut-point was nearly identical to the score that best
discriminated participants with and without dementia (Figure 2). General cognitive
performance factor scores of <50.9 and <40.7 corresponded to MMSE scores of 26/27 and
17/18, respectively. Table 2 provides sensitivity, specificity, positive and negative predictive
values, and likelihood ratio positive and negative statistics for predicting dementia and
CIND for general cognitive performance factor scores corresponding to MMSE scores of 29,
27, 24, 18, and 10. The general cognitive performance factor cut-point of 45.2 correctly
classified 90% of persons with dementia (sensitivity) and 93% of persons without dementia
(specificity). This cut-point is moderately strong for confirming dementia (positive
predictive value = 73%; likelihood ratio positive = 12.8) and has excellent negative
predictive value (98%).
We constructed a crosswalk to show scores on the general cognitive performance factor and
corresponding scores on the MMSE (Figure 4). Irregular levels between each score on the
MMSE and the limited observable range of MMSE evident in this figure underscores the
broader range and better interval scaling properties of the general cognitive performance
factor.
Discussion
We developed a unidimensional factor of cognitive performance in the SAGES study, scaled
it to national norms for adults over 70 years of age living in the US, and evaluated its
criterion and convergent validity. When validated against reference standard diagnoses for
dementia, the score of approximately 45 has a sensitivity of 94% and specificity of 90%
(AUC=0.97), indicating outstanding performance. Convergent validity with the MMSE was
excellent (correlation=0.91, P<0.001). Cognitive tests comprising the general cognitive
performance factor are internally consistent (Cronbach's alpha=0.91). The factor is highly
precise across most of the score range (reliability>0.90). To enhance the clinical relevance
of the scores, we provided correlations with widely used scores for the MMSE. Notably, the
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score of 45 was the optimal cut-point for dementia and also corresponded to an MMSE of
23/24.
General cognitive performance factors previously have been shown to have minimal floor
and ceiling effects, measurement precision over a wide range of cognitive function, and
interval scaling properties that make it an ideally suited measure of change (12,31). We
replicated these findings, and identified meaningful cut-points to further enhance the
potential utility of the measure. Strengths of this study include calibration of the cognitive
composite to a large, nationally representative sample of older adults in which rigorous
reference standard clinical diagnoses were available. With this sample, we were able to
evaluate criterion and convergent validity of the general cognitive performance factor for
detecting cognitive impairment and demonstrate its favorable test performance
characteristics.
Several caveats merit attention. First, the general cognitive performance factor is not
intended to diagnose dementia or MCI. It simply provides a refined cognitive measure,
which like any cognitive measure represents only one piece of the necessary armamentarium
for establishing a clinical diagnosis. Second, seven tests were in common to calibrate
cognitive composites in ADAMS and SAGES, and Bland-Altman plots confirmed they were
similar between studies. Although we are convinced that the general cognitive performance
factors developed in the two samples were equivalent, further research is needed to
determine minimum sample sizes, number of cognitive tests available in common between
studies, and the degree of correlation among tests needed to estimate a reliable composite in
a new sample. Existing research suggests that fewer than five anchor items in an IRT
analysis such as ours is enough to produce reasonably accurate parameter estimates (44);
one previous study used one item in common to calibrate different scales (45). Third, some
criterion contamination is potentially present in our evaluation of criterion validity because
the general cognitive performance factor in ADAMS is a unique combination of shared
variability among test items that were available to clinicians when assigning clinical
diagnoses. However, comparison of AUC's in Supplemental Table 1 for the general factor
and individual cognitive tests revealed the former performed better than most of its
constituent parts. Fourth, positive and negative predictive values in our study are dependent
on base rates, and may differ in other samples. Fifth, while reliability of the general
cognitive performance factor was excellent across a range of performance that included 84%
of the ADAMS population, results suggest it is less reliable at more impaired levels. Future
calibration efforts should consider cognitive tests that are sensitive to impairment in
populations with more severe degrees of dementia. A final caveat is that our approach is not
intended to replace examination and interpretation of individual neuropsychological tests.
Such examination remains an important approach to examine domain-specific cognitive
changes to assist with clinical diagnosis and to understand pathophysiologic correlates of
various cognitive disorders.
An important implication of the present work is the potential of deriving the general
cognitive performance factor to other samples with neuropsychological batteries that have
overlap with the battery used in ADAMS. Extrapolation of these methods holds the potential
for harmonizing batteries to enhance comparability and even synthesize results across
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studies through integrative data analysis. This method would thus address a substantial
limitation for combining existing studies using disparate neuropsychological batteries (46).
Harmonizing samples together with different research designs and demographic
characteristics provides opportunities to make findings more generalizable. Without this
common metric, or at least one test in common across studies, to conduct integrative
analysis, one must resort to comparing multiple data points from normative tests that
potentially measure diverse cognitive domains.
The need for uniform measures of cognitive function, derived using rigorous psychometric
methods, has been recognized by national groups (47). Uniform, psychometrically sound
measures are a central focus of the NIH PROMIS and Toolbox initiatives. Our study is
consistent with these goals. The innovative approach demonstrated here used psychometric
methods to generate a unidimensional general cognitive performance composite with
excellent performance characteristics that can be used to measure cognitive change over
time and across study. We established clinically meaningful, population-based cut-points.
This measure, and the methods used to create it, holds substantial promise for advancing
work to evaluate progression of cognitive functioning over time. Perhaps most importantly,
our methods can facilitate future strategies to integrate cognitive test results across
epidemiologic and clinical studies of cognitive aging.
Conclusions
We created a composite factor for general cognitive performance from widely used tests for
neuropsychological functioning using psychometrically sophisticated methods. We used
publicly available neuropsychological performance data from the Aging, Demographics, and
Memory Study to calibrate general cognitive performance to a nationally representative
sample of adults age 70 and older in the US. This calibration enabled us to describe
cognitive functioning in our study on a nationally representative scale. The general cognitive
performance factor was internally consistent, provided reliable measures of functional
ability across a wide range of cognitive functioning, and demonstrated minimal floor and
ceiling effects. It also demonstrated criterion validity: a cut-point of approximately 45,
corresponding with an MMSE of 23/24, optimally discriminated participants with and
without dementia (sensitivity=0.94; specificity=0.90; AUC=0.97). Our approach has broad
applicability and usefulness to directly compare cognitive performance in new and existing
studies when overlapping items with the ADAMS neuropsychological battery are present.
These methods can facilitate interpretation and synthesis of findings in existing and future
research studies.
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CIND Cognitive impairment without dementia
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Figure 1. Distribution of General Cognitive Performance Score in SAGES and ADAMS
ADAMS: Aging, Demographics, and Memory Study; SAGES: Successful AGing after
Elective Surgery
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Figure 2. Receiver Operator Characteristic Curves for General Cognitive Performance
Predicting CIND and Dementia: Results from ADAMS (n=856)
Legend. In right panel, the general cognitive performance score that best discriminated
dementia participants from other participants was less than 44.8 (sensitivity = 0.94;
specificity = 0.90; right panel). This cut-point correctly classified 93.8% of the sample. The
area under the curve (AUC) was 0.97. In the left panel, the general cognitive performance
score that best discriminated CIND participants from cognitively normal participants was
less than 49.5 (sensitivity = 0.80, specificity = 0.76; Figure 1, left panel). This cut-point
correctly classified 78.5% of the sample. The AUC was 0.84.
CIND: Cognitive impairment without dementia.
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Figure 3. Corresponding Scores and Percentile Ranks for the General Cognitive Performance
Factor and MMSE
Legend. General cognitive performance scores are shown on the top axis. MMSE scores
with the proportion of participants in ADAMS falling below each score are shown on the
bottom x axis. Dotted lines show that approximately 25% of participants have below a 45 on
the general cognitive performance factor and below 24 on the MMSE.
MMSE: Mini-Mental State Examination.
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Figure 4. Crosswalk Between MMSE and General Cognitive Performance Factor: Results from
ADAMS (n=856)
Legend. Crosswalk of scores on the MMSE to the general cognitive performance factor. The
left side of the crosswalk shows MMSE scores (range 0 to 30) and the right side shows
corresponding general cognitive performance scores. To facilitate comparison of the
distribution of general cognitive performance scores against MMSE scores, y-axes are
plotted on an inverse normalized percentile scale. Original units are labeled. We used data
from the Monte Carlo simulation because the distribution of the observed data did not
permit a finely graded linkage between the MMSE and general cognitive performance
factor.
MMSE: Mini-Mental State Examination; GCP: General Cognitive Performance
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Table 1
Neuropsychological Test Batteries in the SAGES and ADAMS Samples
SAGES
(n=300) Mean
± SD
ADAMS
(n=856*)
Mean ± SD
Cognitive domain Test description or effect
size for group difference†
Demographic
 Age, mean ± SD 76.9 ± 5.1 79.0 ± 6.0 0.35
 Age range, years 70, 92 70, 110
 Race, White, n (%) 286 (95.0) 658 (89.3) 0.02
 Years of education, n (%) 0.96
  High school or less 91 (30.3) 638 (62.9)
  College 124 (41.3) 167 (28.7)
  Graduate 86 (28.4) 51 (8.4)
 Sex, female, n (%) 167 (55.6) 501 (60.6) 0.2
Cognitive status, n (%)
 Cognitively normal 276 (92.0) 307 (50.6)
 Cognitive impairment without
dementia
19 (6.3) 241 (35.7)
 Alzheimer s disease 5 (1.7) 308 (13.7)
Neuropsychological test variables
Trails A (Time to complete, seconds)
(48)
42.1 ± 15.1 65.0 ± 45.3 Processing speed Connect a series of
numbers
Trails B (Time to complete, seconds)
(48)
183.7 ± 57.2 154.6 ± 72.7 Processing speed, task-switching Connect an alternating
series of letters and
numbers
Digit Span Forwards (Total number of
digits) (49)
9.9 ± 2.2 8.6 ± 2.1 Attention Repeat a series of pre-
specified random digits
forwards
Digit Span Backwards (Total number
of digits) (49)
6.3 ± 2.1 5.4 ± 2.2 Attention Repeat a series of pre-
specified random digits
backwards
Semantic Fluency (Number of items)
(50)
21.4 ± 6.0 14.5 ± 5.3 Language, executive function Name as many items as
possible in one minute from
a preselected category
Phonemic Fluency (Number of items)
(50)
34.7 ± 12.5 29.3 ± 11.8 Language, executive function Name as many items as
possible in one minute that
begin with letters F, A, or S
(3 trials).
Boston Naming Test - 15 items
(Number of items) (51)
13.3 ± 2.1 13.3 ± 2.2 Language Name objects in a series of
drawings
Symbol Digit Modalities (Total
number of correct numbers) (52)
-- 30.3 ± 11.3 Attention, executive function Match numbers to a series
of symbols
Digit Symbol Substitution (Total
number of correct symbols) (49)
36.0 ± 10.2 -- Attention, executive function Match symbols to a series
of numbers
CERAD word recall – immediate
(Number of words) (53)
-- 16.0 ± 5.8 Episodic memory Sum of 3 trials of recalled
words from a 10-word list
of unrelated nouns
HVLT sum of recall – immediate
(Number of words) (54)
21.3 ± 5.1 -- Episodic memory Sum of 3 trials of recalled
words from a 12-word list
of 4 groups of 3
semantically related nouns
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SAGES
(n=300) Mean
± SD
ADAMS
(n=856*)
Mean ± SD
Cognitive domain Test description or effect
size for group difference†
CERAD word recall – delayed
(Number of words recalled) (53)
-- 0.7 ± 0.4 Episodic long-term memory Recalled words from a
delayed recall trial
HVLT sum of recall – delayed
(Number of words) (54)
0.8 ± 0.3 -- Episodic long-term memory Recalled words from a
delayed recall trial
Visual Search and Attention (Number
of targets) (55)
43.0 ± 9.5 -- Visuospatial function Search for a target letter
amidst other letters
*
In ADAMS, means and percentages calculated using population weights to account for complex sampling. Raw numbers are shown for race,
education, sex, and cognitive status.
†Cohen's d for mean differences and Cohen's h for proportions.
SD: Standard deviation; WMS: Wechsler Memory Scale; HVLT: Hopkins Verbal Learning Test; SD: standard deviation; CERAD: Consortium to
Establish a Registry for Alzheimer's Disease; MMSE: Mini Mental State Examination; SAGES: Successful Aging after Elective Surgery; ADAMS:
Aging, Demographics, and Memory Study.
Missing data. In SAGES, 0.3% of the sample was missing Trails B, Digit Symbol Substitution, and Boston Naming; there was no missingness in
any other cognitive variables. In ADAMS, 10% were missing Trails A, 19% were missing Trails B, 6% were missing Digit Span Forward, 7%
were missing Digit Span Backward, 3% were missing Semantic Fluency, 2% were missing Boston Naming, 16% were missing Symbol Digit
Modalities, 3% were missing CERAD word recall, 4% were missing delayed CERAD word recall, and 8% were missing Phonemic Fluency.
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